Current Health Headlines: Lancet Declines Senate Inquiry, Trump's Drug Pricing Moves, and COVID-19 Vaccine Patent Battle

The Lancet medical journal has refused a request from the U.S. Senate to provide evidence for an inquiry into the origins of the COVID-19 pandemic. The journal's editor-in-chief, Richard Horton, confirmed the decision during an interview at the Reuters Pharma event in Barcelona.

In efforts to address drug pricing and access, former President Donald Trump has urged Congress to reform laws to ensure full-spectrum cannabidiol (CBD) products are accessible to Americans. This follows his administration's initiatives to align drug prices with costs in other developed nations.

Amidst health data privacy concerns, the UK government is investigating how datasets from the health charity UK Biobank were listed for sale on China's Alibaba platforms. This comes as part of heightened scrutiny over personal data security and international data sharing regulations.

(With inputs from agencies.)